References
El-Serag HB: Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 36:S74–S83, 2002
Di Bisceglie AM: Hepatitis C and hepatocellular carcinoma. Hepatology 26:34S–38S, 1997
Ray RB, Meyer K, Ray R: Suppression of apoptotic cell death by hepatitis C virus core protein. Virology 226:176–182, 1996
Sherlock S: Viruses and hepatocellular carcinoma. Gut 35:828–832, 1994
Mas VR, Maluf DG, Stravitz R, et al.: Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: Genes involved in tumor progression. Liver Transpl 10:607–620, 2004
Nishiguchi S, Kuroki T, Nakatani S, et al.: Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 346:1051–1055, 1995
Camma C, Giunta M, Andreone P, Craxi A: Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: An evidence-based approach. J Hepatol 34:593–602, 2001
Sugiura N, Sakai Y, Ebara M, et al.: Detection of hepatocellular carcinoma after interferon therapy for chronic hepatitis C: Clinical study of 26 cases. J Gastroenterol Hepatol 11:535–539, 1996
Sugo H, Kitayama N, Iwata T: Development of hepatocellular carcinoma in a patient with chronic hepatitis C after a complete response to interferon therapy. Acta Hepat Jpn 41:195–198, 2000
Yamada M, Ichikawa M, Matsubara A, Ishiguro Y, Yamada M, Yokoi S: Development of small hepatocellular carcinoma 80 months after clearance of hepatitis C with interferon therapy. Eur J Gastroenterol Hepatol 12:1029–1032, 2000
Makiyama A, Itoh Y, Kasahara A, et al.: Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy. Cancer 101:1616–1622, 2004
Yoshida H, Shiratori Y, Moriyama M, et al.: Interferon therapy reduces the risk for hepatocellular carcinoma: National surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. Ann Intern Med 131:174–181, 1999
Kato Y, Hamasaki K, Aritomi T, Nakao K, Nakata K, Eguchi K: Most of the patients with cirrhosis in Japan die from hepatocellular carcinoma. Oncol Rep 6:1273–1276, 1999
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sieja, K.S., Everson, G.T. De Novo Hepatocellular Carcinomain a Patient with Chronic Hepatitis C 5 Years After Sustained Virologic Response to Interferon/Ribavirin Therapy. Dig Dis Sci 51, 600–602 (2006). https://doi.org/10.1007/s10620-006-3176-1
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10620-006-3176-1